{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T04:19:31Z","timestamp":1764044371971},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2002,10]]},"DOI":"10.1093\/ije\/31.5.1008","type":"journal-article","created":{"date-parts":[[2002,11,15]],"date-time":"2002-11-15T23:03:15Z","timestamp":1037401395000},"page":"1008-1015","source":"Crossref","is-referenced-by-count":24,"title":["Increased risk for hepatitis B-related liver cirrhosis in relatives of patients with hepatocellular carcinoma in northern Taiwan"],"prefix":"10.1093","volume":"31","author":[{"given":"Ming-Whei","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hung-Chuen","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pei-Jer","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-Jen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun-Fan","family":"Liaw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shi-Ming","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shou-Dong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shee-Chan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chih-Lin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chien-Jen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2002,10]]},"reference":[{"key":"key\n\t\t\t\t20170712065408_R1","doi-asserted-by":"crossref","unstructured":"Yu MW, Chang HC, Liaw YF et al. Familial risk of hepatocellular carcinoma among chronic hepatitis B carriers and their relatives. J Natl Cancer Inst2000;92:1159\u201364.","DOI":"10.1093\/jnci\/92.14.1159"},{"key":"key\n\t\t\t\t20170712065408_R2","doi-asserted-by":"crossref","unstructured":"Yu MC, Tong MJ, Govindarajan S, Henderson BE. Nonviral risk factors for hepatocellular carcinoma in a low-risk population, the non-Asians of Los Angeles County, California. J Natl Cancer Inst1991;83:1820\u201326.","DOI":"10.1093\/jnci\/83.24.1820"},{"key":"key\n\t\t\t\t20170712065408_R3","doi-asserted-by":"crossref","unstructured":"Ross RK, Yuan JM, Yu MC et al. Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma. Lancet1992;339:943\u201346.","DOI":"10.1016\/0140-6736(92)91528-G"},{"key":"key\n\t\t\t\t20170712065408_R4","unstructured":"Chen CJ, Yu MW, Liaw YF et al. Chronic hepatitis B carriers with null genotypes of glutathione S-transferase M1 and T1 polymorphisms who are exposed to aflatoxin are at increased risk of hepatocellular carcinoma. Am J Hum Genet1996;59:128\u201334."},{"key":"key\n\t\t\t\t20170712065408_R5","doi-asserted-by":"crossref","unstructured":"Yu MW, Lien JP, Chiu YH, Santella RM, Liaw YF, Chen CJ. Effect of aflatoxin metabolism and DNA adduct formation on hepatocellular carcinoma among chronic hepatitis B carriers in Taiwan. J Hepatol1997;27:320\u201330.","DOI":"10.1016\/S0168-8278(97)80178-X"},{"key":"key\n\t\t\t\t20170712065408_R6","doi-asserted-by":"crossref","unstructured":"Yu MW, Gladek-Yarborough A, Chiamprasert S, Santella RM, Liaw YF, Chen CJ. Cytochrome P450 2E1 and glutathione S-transferase M1 polymorphisms and susceptibility to hepatocellular carcinoma. Gastroenterology1995;109:1266\u201373.","DOI":"10.1016\/0016-5085(95)90587-1"},{"key":"key\n\t\t\t\t20170712065408_R7","doi-asserted-by":"crossref","unstructured":"Yu MW, Chiu YH, Chiang YC et al. Plasma carotenoids, glutathione S-transferase M1 and T1 genetic polymorphisms, and risk of hepatocellular carcinoma: independent and interactive effects. Am J Epidemiol1999;149:621\u201329.","DOI":"10.1093\/oxfordjournals.aje.a009862"},{"key":"key\n\t\t\t\t20170712065408_R8","doi-asserted-by":"crossref","unstructured":"Yu MW, Chiu YH, Yang SY et al. Cytochrome P450 1A1 genetic polymorphisms and risk of hepatocellular carcinoma among chronic hepatitis B carriers. Br J Cancer1999;80:598\u2013603.","DOI":"10.1038\/sj.bjc.6690397"},{"key":"key\n\t\t\t\t20170712065408_R9","doi-asserted-by":"crossref","unstructured":"Yu MW, Yang SY, Chiu YH, Chiang YC, Liaw YF, Chen CJ. A p53 genetic polymorphism as a modulator of hepatocellular carcinoma risk in relation to chronic liver disease, familial tendency, and cigarette smoking in hepatitis B carriers. Hepatology1999;29:697\u2013702.","DOI":"10.1002\/hep.510290330"},{"key":"key\n\t\t\t\t20170712065408_R10","doi-asserted-by":"crossref","unstructured":"Yu MW, Pai CI, Yang SY et al. Role of N-acetyltransferase polymorphisms in hepatitis B-related hepatocellular carcinoma: impact on risk of smoking. Gut2000;47:703\u201309.","DOI":"10.1136\/gut.47.5.703"},{"key":"key\n\t\t\t\t20170712065408_R11","doi-asserted-by":"crossref","unstructured":"Yu MW, Chen CJ. Hepatitis B and C viruses in the development of hepatocellular carcinoma. Crit Rev Oncol Hematol1994;17:71\u201391.","DOI":"10.1016\/1040-8428(94)90020-5"},{"key":"key\n\t\t\t\t20170712065408_R12","doi-asserted-by":"crossref","unstructured":"Stevens CE, Beasley RP, Tsui J, Lee WC. Vertical transmission of hepatitis B antigen in Taiwan. N Engl J Med1975;292:771\u201374.","DOI":"10.1056\/NEJM197504102921503"},{"key":"key\n\t\t\t\t20170712065408_R13","doi-asserted-by":"crossref","unstructured":"Beasley RP. Hepatitis B virus: the major etiology of hepatocellular carcinoma. Cancer1988;61:1942\u201356.","DOI":"10.1002\/1097-0142(19880515)61:10<1942::AID-CNCR2820611003>3.0.CO;2-J"},{"key":"key\n\t\t\t\t20170712065408_R14","doi-asserted-by":"crossref","unstructured":"Chen PJ, Chen DS. Hepatitis B virus infection and hepatocellular carcinoma: molecular genetics and clinical perspectives. Semin Liver Dis1999;19:253\u201362.","DOI":"10.1055\/s-2007-1007115"},{"key":"key\n\t\t\t\t20170712065408_R15","doi-asserted-by":"crossref","unstructured":"Popper H, Shafritz DA, Hoofnagle JH. Relation of the hepatitis B virus carrier state to hepatocellular carcinoma. Hepatology1987;7:764\u201372.","DOI":"10.1002\/hep.1840070425"},{"key":"key\n\t\t\t\t20170712065408_R16","doi-asserted-by":"crossref","unstructured":"Liaw YF, Tai DI, Chu CM, Chen TJ. The development of cirrhosis in patients with chronic type B hepatitis: a prospective study. Hepatology1988;8:493\u201396.","DOI":"10.1002\/hep.1840080310"},{"key":"key\n\t\t\t\t20170712065408_R17","doi-asserted-by":"crossref","unstructured":"Yu MW, Hsu FC, Sheen IS et al. Prospective study of hepatocellular carcinoma and liver cirrhosis in asymptomatic chronic hepatitis B virus carriers. Am J Epidemiol1997;145:1039\u201347.","DOI":"10.1093\/oxfordjournals.aje.a009060"},{"key":"key\n\t\t\t\t20170712065408_R18","unstructured":"Yang PM, Huang GT, Lin JT et al. Ultrasonography in the diagnosis of benign diffuse parenchymal liver diseases: a prospective study. J Formosan Med Assoc1988;87:966\u201377."},{"key":"key\n\t\t\t\t20170712065408_R19","doi-asserted-by":"crossref","unstructured":"Lin DY, Sheen IS, Chiu CT, Lin SM, Kuo YC, Liaw YF. Ultrasonographic changes of early liver cirrhosis in chronic hepatitis B: a longitudinal study. J Clin Ultrasound1993;21:303\u201308.","DOI":"10.1002\/jcu.1870210502"},{"key":"key\n\t\t\t\t20170712065408_R20","doi-asserted-by":"crossref","unstructured":"Liang KY, Zeger SL. Regression analysis for correlated data. Annu Rev Pub Health1993;14:43\u201368.","DOI":"10.1146\/annurev.pu.14.050193.000355"},{"key":"key\n\t\t\t\t20170712065408_R21","doi-asserted-by":"crossref","unstructured":"Tong MJ, Weiner JM, Ashcavai MW, Vyas GN. Evidence for clustering of hepatitis B virus infection in families of patients with primary hepatocellular carcinoma. Cancer1979;44:2338\u201342.","DOI":"10.1002\/1097-0142(197912)44:6<2338::AID-CNCR2820440650>3.0.CO;2-I"},{"key":"key\n\t\t\t\t20170712065408_R22","unstructured":"Yu MW, You SL, Chang AS, Lu SN, Liaw YF, Chen CJ. Association between hepatitis C virus antibodies and hepatocellular carcinoma in Taiwan. Cancer Res1991;51:5621\u201325."},{"key":"key\n\t\t\t\t20170712065408_R23","doi-asserted-by":"crossref","unstructured":"Lee SD, Chan CY, Wang YJ et al. Seroepidemiology of hepatitis C virus infection in Taiwan. Hepatology1991;13:830\u201333.","DOI":"10.1002\/hep.1840130505"},{"key":"key\n\t\t\t\t20170712065408_R24","doi-asserted-by":"crossref","unstructured":"Chang HC, Yu MW, Lu CF, Chiu YH, Chen CJ. Risk factors associated with hepatitis C virus infection in Taiwanese government employees. Epidemiol Infect2001;126:291\u201399.","DOI":"10.1017\/S0950268801005362"},{"key":"key\n\t\t\t\t20170712065408_R25","doi-asserted-by":"crossref","unstructured":"Sun CA, Chen HC, Lu CF et al. Transmission of hepatitis C virus in Taiwan: prevalence and risk factors based on a nationwide survey. J Med Virol1999;59:290\u201396.","DOI":"10.1002\/(SICI)1096-9071(199911)59:3<290::AID-JMV5>3.0.CO;2-R"},{"key":"key\n\t\t\t\t20170712065408_R26","doi-asserted-by":"crossref","unstructured":"Caporaso N, Ascione A, Stroffolini T, Investigators of an Italian Multicenter Group. Spread of hepatitis C virus infection within families. J Viral Hepat1998;5:67\u201372.","DOI":"10.1046\/j.1365-2893.1998.00085.x"},{"key":"key\n\t\t\t\t20170712065408_R27","doi-asserted-by":"crossref","unstructured":"Alvarez-Mu\u00f1oz MT, Vences-Aviles MA, Damacio L et al. Hepatitis C virus RNA (HCV-RNA) in blood donors and family members seropositive for anti-HCV antibodies. Arch Med Res2001;32:442\u201345.","DOI":"10.1016\/S0188-4409(01)00307-1"},{"key":"key\n\t\t\t\t20170712065408_R28","doi-asserted-by":"crossref","unstructured":"Tai DI, Changchien CS, Hung CS, Chen CJ. Replication of hepatitis B virus in first-degree relatives of patients with hepatocellular carcinoma. Am J Trop Med Hyg1999;61:716\u201319.","DOI":"10.4269\/ajtmh.1999.61.716"},{"key":"key\n\t\t\t\t20170712065408_R29","doi-asserted-by":"crossref","unstructured":"Kao JH, Chen PJ, Lai MY, Chen DS. Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B. Gastroenterology2000;118:554\u201359.","DOI":"10.1016\/S0016-5085(00)70261-7"},{"key":"key\n\t\t\t\t20170712065408_R30","unstructured":"Shen FM, Lee MK, Gong HM, Cai XQ, King MC. Complex segregation analysis of primary hepatocellular carcinoma in Chinese families: interaction of inherited susceptibility and hepatitis B viral infection. Am J Hum Genet1991;49:88\u201393."},{"key":"key\n\t\t\t\t20170712065408_R31","doi-asserted-by":"crossref","unstructured":"Khoury MJ, Beaty TH, Liang KY. Can familial aggregation of disease be explained by familial aggregation of environmental risk factors? Am J Epidemiol1988;127:674\u201383.","DOI":"10.1093\/oxfordjournals.aje.a114842"},{"key":"key\n\t\t\t\t20170712065408_R32","doi-asserted-by":"crossref","unstructured":"Hopper JL, Carlin JB. Familial aggregation of a disease consequent upon correlation between relatives in a risk factor measured on a continuous scale. Am J Epidemiol1992;136:1138\u201347.","DOI":"10.1093\/oxfordjournals.aje.a116580"},{"key":"key\n\t\t\t\t20170712065408_R33","doi-asserted-by":"crossref","unstructured":"Wong DKH, Cheung AM, O\u2019Rourke K, Naylor CD, Detsky AS, Heathcote J. Effect of alpha-interferone treatment in patients with hepatitis B e antigen-positive chronic hepatitis B: a meta-analysis. Ann Intern Med1993;119:312\u201323.","DOI":"10.7326\/0003-4819-119-4-199308150-00011"},{"key":"key\n\t\t\t\t20170712065408_R34","doi-asserted-by":"crossref","unstructured":"Lok ASF, Wu PC, Lai CL et al. A controlled trial of interferon with or without prednisone priming for chronic hepatitis B. Gastroenterology1992;102:2091\u201397.","DOI":"10.1016\/0016-5085(92)90337-X"},{"key":"key\n\t\t\t\t20170712065408_R35","doi-asserted-by":"crossref","unstructured":"Nevens F, Main J, Honkoop P et al. Lamivudine therapy for chronic hepatitis B: a six-month randomized dose-ranging study. Gastroenterology1997;113:1258\u201363.","DOI":"10.1053\/gast.1997.v113.pm9322520"},{"key":"key\n\t\t\t\t20170712065408_R36","doi-asserted-by":"crossref","unstructured":"Lai CL, Chien RN, Leung NWY et al. A one-year trial of lamivudine for chronic hepatitis B. N Engl J Med1998;339:61\u201368.","DOI":"10.1056\/NEJM199807093390201"}],"container-title":["International Journal of Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ije\/article-pdf\/31\/5\/1008\/18479038\/311008.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,23]],"date-time":"2017-08-23T03:48:11Z","timestamp":1503460091000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ije\/article-lookup\/doi\/10.1093\/ije\/31.5.1008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,10]]},"references-count":36,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2002,10]]},"published-print":{"date-parts":[[2002,10]]}},"URL":"https:\/\/doi.org\/10.1093\/ije\/31.5.1008","relation":{},"ISSN":["1464-3685","0300-5771"],"issn-type":[{"value":"1464-3685","type":"electronic"},{"value":"0300-5771","type":"print"}],"subject":[],"published":{"date-parts":[[2002,10]]}}}